IRCT2014042612438N6
The effect of hepatoheal tablet on non alcoholic fatty liver
The effect of hepatoheal tablet on liver enzymes of patients with non alcoholic fatty liver and its comparison with vitamin E
Barij Research Center of Medicinal Herbs·Phase 2/3·Iranian Registry Of Clinical Trial·drugCompleted
Study focus
- Disease/Condition
- Nonalcoholic fatty liver disease (NAFLD)
- Study type
- Interventional
- Intervention type
- drug
Sponsor & location
- Primary sponsor
- Barij Research Center of Medicinal Herbs
- Location
- Iran
Timeline & enrollment
- Phase
- Phase 2/3
- Start date
- May 22, 2014
- End date
- N/A
ICD-10 classifications
Liver disease, unspecifiedInflammatory liver disease, unspecifiedAlcoholic liver disease, unspecifiedAlcoholic fatty liverToxic liver disease, unspecified
Data source
- Registry
- Iranian Registry Of Clinical Trial
- Trial ID
- IRCT2014042612438N6
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for IRCT2014042612438N6 through Pure Global AI's free database. This Phase 2/3 trial is sponsored by Barij Research Center of Medicinal Herbs and is currently Completed. The study focuses on Nonalcoholic fatty liver disease (NAFLD).
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Iranian Registry Of Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.